IRX-2 modified manufacturing process

Details for Australian Patent Application No. 2009244617 (hide)

Owner IRx Therapeutics, Inc.

Inventors Brandwein, Harvey J.; Fennington, George J.

Agent Lord and Company

Pub. Number AU-A-2009244617

PCT Pub. Number WO2009/137238

Priority 61/044,674 14.04.08 US

Filing date 14 April 2009

Wipo publication date 12 November 2009

International Classifications

C12P 21/04 (2006.01) Preparation of peptides or proteins - Cyclic or bridged peptides or polypeptides, e.g. bacitracin

C12N 5/02 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Propagation of single cells or cells in suspension

C12N 5/071 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Vertebrate cells or tissues, e.g. human cells or tissues

C12N 13/00 (2006.01) Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves

Event Publications

9 December 2010 PCT application entered the National Phase

  PCT publication WO2009/137238 Priority application(s): WO2009/137238

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009244624-Fluoropolymer coated membranes

2009244616-Method for determining adequacy of seismic data coverage of a subsurface area being surveyed and its application to selecting sensor array geometry